Jim Cramer Says to Buy Shares of Danaher on the Dip
The life sciences and medical technology company beat earnings estimates in the third quarter but narrowed its 2022 bioprocessing revenue growth forecast.
Stay updated with breaking news from Cramer Charitable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The life sciences and medical technology company beat earnings estimates in the third quarter but narrowed its 2022 bioprocessing revenue growth forecast.
CNBC’s “Mad Money host” Jim Cramer on Friday told investors that stocks will likely continue to do well as long as the economy holds up.
CNBC’s “Mad Money host” Jim Cramer on Friday told investors that stocks will likely continue to do well as long as the economy holds up.
CNBC’s “Mad Money host” Jim Cramer on Friday told investors that stocks will likely continue to do well as long as the economy holds up.
CNBC’s “Mad Money host” Jim Cramer on Friday told investors that stocks will likely continue to do well as long as the economy holds up.